Relay Therapeutics (RLAY) Amortizatization of Intangibles (2019 - 2026)

Relay Therapeutics (RLAY) reported Amortizatization of Intangibles of $782000.0 for Q1 2026, down 51.03% year-over-year from $1.6 million in Q1 2025, and down 8.75% quarter-over-quarter from $857000.0 in Q4 2025.

Relay Therapeutics (RLAY) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends

Relay Therapeutics (RLAY) has 8 years of Amortizatization of Intangibles data on file, last reported at $782000.0 in Q1 2026.

  • Amortizatization of Intangibles for Q1 2026 came in at $782000.0, down 51.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.1 million (down 59.66% YoY), and the FY2025 annual result was $4.9 million, down 59.81% from the prior year.
  • Amortizatization of Intangibles retreated to $782000.0 in Q1 2026 per RLAY's latest filing, from $857000.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $3.7 million in Q4 2023 and troughed at -$681000.0 in Q1 2022.
  • A 5-year average of $1.6 million and a median of $1.6 million in 2025 frame the typical range for Amortizatization of Intangibles.
  • The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles sank 345.1% in 2022, then soared 945.88% in 2023.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $385000.0 in 2022, then soared by 852.99% to $3.7 million in 2023, then tumbled by 40.56% to $2.2 million in 2024, then slumped by 60.71% to $857000.0 in 2025, then retreated by 8.75% to $782000.0 in 2026.
  • Business Quant data shows RLAY's Amortizatization of Intangibles at $782000.0 in Q1 2026, $857000.0 in Q4 2025, and $1.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13,267.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Relay Therapeutics 2.86 Bn 2.86 Bn - 782,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 782,000.00
Mar 31, 2026 782,000.00
Dec 31, 2025 857,000.00
Dec 31, 2025 857,000.00
Sep 30, 2025 1.10 Mn
Sep 30, 2025 1.10 Mn
Jun 30, 2025 1.39 Mn
Jun 30, 2025 1.39 Mn
Mar 31, 2025 1.60 Mn
Mar 31, 2025 1.60 Mn
Dec 31, 2024 2.18 Mn
Dec 31, 2024 2.18 Mn
Sep 30, 2024 3.18 Mn
Sep 30, 2024 3.18 Mn
Jun 30, 2024 3.29 Mn
Jun 30, 2024 3.29 Mn
Mar 31, 2024 3.67 Mn
Mar 31, 2024 3.67 Mn
Dec 31, 2023 3.67 Mn
Dec 31, 2023 3.67 Mn